The Pitch: This JLabs D.C. company wants to bring more diversity to clinical trials

Editor’s note: Welcome to The Pitch, a DC Inno special feature in which we spotlight young local startups led by underrepresented founders. These companies may not have much (or any) funding or revenue, but they do have plans — and they’re taking the initial steps to make things happen. Each month, we’ll highlight a different venture in the D.C.-area landscape, with an intention of following their journeys from this point forward. This is the third installment. Previously we have featured CarpeDM and Old Dominion Flower Co.

Delmonize “Del” Smith’s mother, a health care professional, contracted tuberculosis and passed away after various drugs failed to treat the infection. He soon learned his biological father had died a year prior from cancer.

Those experiences helped lead to Acclinate Inc., which aims to address the underlying issue — that minority groups predisposed to certain diseases aren’t adequately represented in the clinical trials for those very treatments.

It’s…

Read the full story from the Washington Business Journal.
Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up